Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry
|
January 15, 2021
Dr. Sprengers et al. Reply
Jan J Sprengers, Dorinde M van Andel, Hilgo Bruining
Journal of Autism and Developmental Disorders
|
January 10, 2023
Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial
Dorinde M van Andel, Jan J Sprengers, Marsh Königs, et al.
Molecular Autism
|
May 9, 2020
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study
Dorinde M van Andel, Jan J Sprengers, Bob Oranje, et al.
Journal of Patient-Reported Outcomes
|
November 17, 2021
The sensory-reactivity PROM set: identification of a parent reported outcome measure set for autism spectrum disorder
Dorinde M van Andel, Henk F van Stel, Floortje E Scheepers, et al.
The International Journal of Eating Disorders
|
May 18, 2026
Validation of the ED-15-NL, a Brief Session-by-Session Questionnaire to Measure Changes in Eating Disorder Cognitions and Behaviors
Caya H van Eikenhorst, Benny van der Vijgh, Sanne F W Marcic-van Doornik, et al.
Frontiers in Psychiatry
|
February 25, 2022
Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial
Dorinde M van Andel, Jan J Sprengers, Mandy G Keijzer-Veen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
July 31, 2020
Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial
Jan J Sprengers, Dorinde M van Andel, Nicolaas P A Zuithoff, et al.
Frontiers in Neuroscience
|
June 1, 2022
Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study
Erika L Juarez-Martinez, Dorinde M van Andel, Jan J Sprengers, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 10, 2021
Prediction of Behavioral Improvement Through Resting-State Electroencephalography and Clinical Severity in a Randomized Controlled Trial Testing Bumetanide in Autism Spectrum Disorder
Erika L Juarez-Martinez, Jan J Sprengers, Gianina Cristian, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of the American Academy of Child and Adolescent Psychiatry
|
January 15, 2021
Dr. Sprengers et al. Reply
Jan J Sprengers, Dorinde M van Andel, Hilgo Bruining
Journal of Autism and Developmental Disorders
|
January 10, 2023
Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial
Dorinde M van Andel, Jan J Sprengers, Marsh Königs, et al.
Molecular Autism
|
May 9, 2020
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study
Dorinde M van Andel, Jan J Sprengers, Bob Oranje, et al.
Journal of Patient-Reported Outcomes
|
November 17, 2021
The sensory-reactivity PROM set: identification of a parent reported outcome measure set for autism spectrum disorder
Dorinde M van Andel, Henk F van Stel, Floortje E Scheepers, et al.
The International Journal of Eating Disorders
|
May 18, 2026
Validation of the ED-15-NL, a Brief Session-by-Session Questionnaire to Measure Changes in Eating Disorder Cognitions and Behaviors
Caya H van Eikenhorst, Benny van der Vijgh, Sanne F W Marcic-van Doornik, et al.
Frontiers in Psychiatry
|
February 25, 2022
Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial
Dorinde M van Andel, Jan J Sprengers, Mandy G Keijzer-Veen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
July 31, 2020
Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial
Jan J Sprengers, Dorinde M van Andel, Nicolaas P A Zuithoff, et al.
Frontiers in Neuroscience
|
June 1, 2022
Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study
Erika L Juarez-Martinez, Dorinde M van Andel, Jan J Sprengers, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 10, 2021
Prediction of Behavioral Improvement Through Resting-State Electroencephalography and Clinical Severity in a Randomized Controlled Trial Testing Bumetanide in Autism Spectrum Disorder
Erika L Juarez-Martinez, Jan J Sprengers, Gianina Cristian, et al.
Page
of 1